ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02114229
Brief Title: Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors (SJATRT)

First Submitted : April 11, 2014
First Submitted that Met QC Criteria : April 11, 2014
First Posted : April 15, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 16, 2019
Last Update Posted : January 18, 2019